Biogen Inc. buy Wells Fargo & Company
Start price
09.11.23
/
50%
€210.20
Target price
09.11.24
€340.62
Performance (%)
-22.79%
End price
10.11.24
€162.30
Summary
This prediction ended on 10.11.24 with a price of €162.30. The price of Biogen Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -22.79%. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | -2.733% | -2.733% | 26.432% |
| iShares Core DAX® | 0,46 % | -1,53 % | 9,99 % |
| iShares Nasdaq 100 | -1,79 % | -5,38 % | -0,88 % |
| iShares Nikkei 225® | 5,12 % | 8,05 % | 30,03 % |
| iShares S&P 500 | -1,76 % | -3,82 % | -0,21 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target raised by analysts at Wells Fargo & Company from $343.00 to $365.00. They now have an "overweight" rating on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten